Inhaled Bricanyl has been shown to provide rapid improvement in lung function in adults with acute asthma. Bricanyl Turbuhaler has been shown to be at least as effective as Bricanyl pMDI* plus spacer.
Very young children with acute asthma can be effectively treated with nebulized Bricanyl. Bricanyl Turbuhaler can be used from the age of 5 years, or even younger, for relief of episodic symptoms.
*No longer available
| 1. Tönnesen F, et al. Chest 1994; 105: 697–700 |
| |
Bricanyl Turbuhaler is at least as effective as Bricanyl pMDI* plus spacer in the treatment of acute bronchial obstruction in adults.
Bronchodilating affect in acute bronchial obstruction
The bronchodilating effect of terbutaline inhaled via Turbuhaler was compared with terbutaline inhaled via a pressurized metered-dose inhaler plus Nebuhaler in 68 consecutive patients attending the emergency department with acute, severe bronchial obstruction.
Adapted from Tönnesen et al., 1994.
*No longer available |
| |
| 2. Rufin, P et al. Arch Dis Child 1991; 66: 1465 |
| |
Bricanyl Turbuhaler was at least as effective as Bricanyl pMDI* plus spacer in the treatment of children above the age of 5 years with moderately acute asthma.
Bricanyl improves lung function in children with acute asthma
22 children attending the hospital with acute wheeze were included in an open, randomized, parallel group study comparing the efficacy of 0.5 mg of terbutaline given either via Turbuhaler, or with a pressurized metered-dose inhaler attached to Nebuhaler.
Adapted from Rufin et al., 1991.
*No longer available |
| |
| 3. Portnoy J, et al. Ann Allergy 1988; 60: 368–71 |
| |
Good clinical effects were observed in children, aged 2–13 years, with acute asthma when Bricanyl solution for nebulization was administered in doses of 1–12 mg/hour over 1–24 hours.
Good clinical effects of Bricanyl nebulizing solution
Duration of therapy, pulse, and respiration rate for 12 patients. *Pre-treatment values were obtained at the start of continuous therapy; during, values at 1–2 hours into treatment; and post, values at the time that continuous therapy was discontinued.
Adapted from Portnoy et al., 1988. |
| |
back to top 
|
|
